244 related articles for article (PubMed ID: 18952105)
21. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.
Handel A; Longini IM; Antia R
PLoS Comput Biol; 2007 Dec; 3(12):e240. PubMed ID: 18069885
[TBL] [Abstract][Full Text] [Related]
22. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
[TBL] [Abstract][Full Text] [Related]
23. [The use of antiviral agents during an (impending) influenza pandemic].
Opstelten W; van Steenbergen JE; van Essen GA; Van der Sande MA
Ned Tijdschr Geneeskd; 2007 May; 151(18):1008-12. PubMed ID: 17508684
[TBL] [Abstract][Full Text] [Related]
24. The evolution of influenza resistance and treatment.
Weinstock DM; Zuccotti G
JAMA; 2009 Mar; 301(10):1066-9. PubMed ID: 19255112
[No Abstract] [Full Text] [Related]
25. Intermittent treatment of severe influenza.
Deecke L; Dobrovolny HM
J Theor Biol; 2018 Apr; 442():129-138. PubMed ID: 29355540
[TBL] [Abstract][Full Text] [Related]
26. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
[No Abstract] [Full Text] [Related]
27. [Mathematical modeling of the novel influenza A (H1N1) virus and evaluation of the epidemic response strategies in the Republic of Korea].
Suh M; Lee J; Chi HJ; Kim YK; Kang DY; Hur NW; Ha KH; Lee DH; Kim CS
J Prev Med Public Health; 2010 Mar; 43(2):109-16. PubMed ID: 20383043
[TBL] [Abstract][Full Text] [Related]
28. 2012-2013 influenza update: hitting a rapidly moving target.
Jin XW; Mossad SB
Cleve Clin J Med; 2012 Nov; 79(11):777-84. PubMed ID: 23125327
[TBL] [Abstract][Full Text] [Related]
29. [Sensitivity of the epidemic and pandemic influenza virus strains to zanamivir (Relenze) in in vitro experiments].
L'vov DK; Burtseva EI; Galegov GA; Beliakova NV; Shevchenko ES; Kolobukhina LV; Merkulova LN; Prilipov AG; Leneva IA; Baranov NI; Gorelikov VN; Abramov DD
Vopr Virusol; 2010; 55(6):10-4. PubMed ID: 21381333
[TBL] [Abstract][Full Text] [Related]
30. Influenza drug resistance.
Pizzorno A; Abed Y; Boivin G
Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
[TBL] [Abstract][Full Text] [Related]
31. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.
Stilianakis NI; Perelson AS; Hayden FG
J Infect Dis; 1998 Apr; 177(4):863-73. PubMed ID: 9534957
[TBL] [Abstract][Full Text] [Related]
32. Optimal control for pandemic influenza: the role of limited antiviral treatment and isolation.
Lee S; Chowell G; Castillo-Chávez C
J Theor Biol; 2010 Jul; 265(2):136-50. PubMed ID: 20382168
[TBL] [Abstract][Full Text] [Related]
33. The effect of population structure on the emergence of drug resistance during influenza pandemics.
Débarre F; Bonhoeffer S; Regoes RR
J R Soc Interface; 2007 Oct; 4(16):893-906. PubMed ID: 17609176
[TBL] [Abstract][Full Text] [Related]
34. Preparing for the next influenza pandemic.
van Dalen PJ; Wijdenes C
Neth J Med; 2005 Oct; 63(9):337-8. PubMed ID: 16244379
[TBL] [Abstract][Full Text] [Related]
35. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.
Hu Y; Lu S; Song Z; Wang W; Hao P; Li J; Zhang X; Yen HL; Shi B; Li T; Guan W; Xu L; Liu Y; Wang S; Zhang X; Tian D; Zhu Z; He J; Huang K; Chen H; Zheng L; Li X; Ping J; Kang B; Xi X; Zha L; Li Y; Zhang Z; Peiris M; Yuan Z
Lancet; 2013 Jun; 381(9885):2273-9. PubMed ID: 23726392
[TBL] [Abstract][Full Text] [Related]
36. Antiviral resistance in influenza viruses--implications for management and pandemic response.
Hayden FG
N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
[No Abstract] [Full Text] [Related]
37. Neuraminidase inhibitors and their role in avian and pandemic influenza.
Crusat M; de Jong MD
Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
[TBL] [Abstract][Full Text] [Related]
38. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.
Ferraris O; Lina B
J Clin Virol; 2008 Jan; 41(1):13-9. PubMed ID: 18055254
[TBL] [Abstract][Full Text] [Related]
39. Pandemic influenza: overview of vaccines and antiviral drugs.
Cox MM
Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
[TBL] [Abstract][Full Text] [Related]
40. Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
McCaw JM; Wood JG; McCaw CT; McVernon J
PLoS One; 2008 Jun; 3(6):e2362. PubMed ID: 18523549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
